Class I
Ongoing
Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLE…
Why: Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
- Company
- American Regent, Inc.
Shirley, NY, United States - Reported
- Aug 26, 2026
- Recall started
- Jul 24, 2026
- Where sold
- Nationwide within the U.S
- Amount
- 86,100 vials
- Full product description
- Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
- Lots / codes affected
- Lot #: 25202, Exp. Date: 11/30/2026.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.